EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of CYP3A4-Mediated Interactions of Gefitinib and Erlotinib Using Physiologically-Based Pharmacokinetic Models

Yearin Jun, So Jin Lee, Soo Kyung Bae, Soo Hyeon Bae

Drug Targets and Therapeutics · 31.03.2026 · 5 (1) · 12-23

DOI: 10.58502/dtt.26.0006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Targets and Therapeutics, erschienen am 31.03.2026. Verfasst von Yearin Jun und 3 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Jun, Y., Lee, S. J., Bae, S. K., & Bae, S. H. (2026). Evaluation of CYP3A4-Mediated Interactions of Gefitinib and Erlotinib Using Physiologically-Based Pharmacokinetic Models. Drug Targets and Therapeutics, 5(1), 12-23. https://doi.org/10.58502/dtt.26.0006

Vancouver

Jun Y, Lee SJ, Bae SK, Bae SH. Evaluation of CYP3A4-Mediated Interactions of Gefitinib and Erlotinib Using Physiologically-Based Pharmacokinetic Models. Drug Targets and Therapeutics. 2026;5(1):12-23. doi:10.58502/dtt.26.0006

BibTeX
@article{Jun2026,
  author = {Jun, Yearin and Lee, So Jin and Bae, Soo Kyung and Bae, Soo Hyeon},
  title = {Evaluation of CYP3A4-Mediated Interactions of Gefitinib and Erlotinib Using Physiologically-Based Pharmacokinetic Models},
  journal = {Drug Targets and Therapeutics},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {12--23},
  doi = {10.58502/dtt.26.0006}
}
Kostenlos starten →